Physician profile
Gerald Vogel
NPI 1366532343
$1,547.72
in general payments reported to CMS, 2019-2025
12 companies · $68.03 in 2025
The $68.03 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $134 · 2021: $529 · 2022: $202 · 2023: $218 · 2024: $106 · 2025: $68.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $806.66 | 2019-2025 | Bexsero, Pediarix, Penmenvy |
| Sobi, INC | $151.27 | 2019-2021 | |
| Pfizer INC. | $119.18 | 2019-2024 | |
| Kaleo, INC. | $108.35 | 2022-2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $96.74 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.14 | 2020-2021 | |
| Vertical Pharmaceuticals, LLC | $59.24 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $47.54 | 2023-2025 | Kristalose |
| Seqirus USA INC | $44.39 | 2021-2023 | Flucelvax Quadrivalent |
| Corium, LLC | $22.72 | 2024 | Azstarys |
| Ultragenyx Pharmaceutical INC. | $15.12 | 2024 | Crysvita |
| Verrica Pharmaceuticals INC. | $14.37 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Vogel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.